| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $232.3M | -67.9% |
| R&D Expense | $54.9M | +17.8% |
| SG&A Expense | $152.9M | +16.4% |
| Operating Income | -$37.0M | -113.1% |
| Interest Expense | $6.8M | +0.4% |
| Pre-tax Income | -$4.4M | -101.5% |
| Income Tax | $2.0M | +76.9% |
| Net Income | -$6.4M | -102.2% |
| EPS (Basic) | -$0.05 | -102.2% |
| EPS (Diluted) | -$0.05 | -102.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $150.3M | -25.6% |
| Accounts Receivable | $40.6M | -72.0% |
| Inventory | $53.3M | -10.4% |
| Current Assets | $859.1M | -6.3% |
| Total Assets | $997.1M | +1.1% |
| Current Liabilities | $62.2M | -58.6% |
| Total Liabilities | $375.0M | -7.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $100.6M | +60.3% |
| Capital Expenditures | $4.1M | -42.5% |
| Investing Cash Flow | -$153.9M | +51.3% |
| Financing Cash Flow | $1.4M | -92.9% |
| Free Cash Flow | $96.5M | +73.6% |
| Stockholders' Equity |
| $622.1M |
| +7.1% |